NorthStar Asset Management (Pennsylvania)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-990
Closed -$203K 110
2017
Q3
$203K Hold
990
0.09% 103
2017
Q2
$241K Hold
990
0.11% 99
2017
Q1
$237K Sell
990
-50
-5% -$11.6K 0.11% 104
2016
Q4
$219K Sell
1,040
-7,519
-88% -$1.56M 0.1% 109
2016
Q3
$1.97M Sell
8,559
-10,515
-55% -$2.57M 0.83% 37
2016
Q2
$4.41M Buy
19,074
+920
+5% +$212K 1.84% 15
2016
Q1
$4.87M Buy
18,154
+190
+1% +$54.4K 2.08% 14
2015
Q4
$5.61M Buy
+17,964
New +$5.35M 2.39% 11
2015
Q2
Sell
-5,649
Closed -$1.68M 108
2015
Q1
$1.68M Buy
+5,649
New +$1.61M 0.72% 41

Other funds holding AGN

NorthStar Asset Management (Pennsylvania)'s AGN Position: Q4 2017 in Review

NorthStar Asset Management (Pennsylvania) sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 990 shares — an estimated $203K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $5.61M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • NorthStar Asset Management (Pennsylvania) reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • NorthStar Asset Management (Pennsylvania) sold 990 Allergan plc shares in Q4 2017, an estimated $203K.
  • NorthStar Asset Management (Pennsylvania) first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • NorthStar Asset Management (Pennsylvania)'s Allergan plc position peaked at $5.61M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q4 2017, filed 26 Jan 2018.